June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of retinal viability after simulation of vitreoretinal surgery in porcine eyes ex vivo
Author Affiliations & Notes
  • Mario Romano
    Ophthalmology, Humanitas Gavazzeni - Castelli, Bergamo, Italy
    Ophthalmology, Humanitas University, Milan, Italy
  • Laura Giurgola
    R&D, Alchimia srl, Ponte San Nicolò, Italy
  • Claudio Gatto
    R&D, Alchimia srl, Ponte San Nicolò, Italy
  • Jana D'Amato Tothova
    R&D, Alchimia srl, Ponte San Nicolò, Italy
  • Footnotes
    Commercial Relationships   Mario Romano, None; Laura Giurgola, Alchimia srl (E); Claudio Gatto, Alchimia srl (E); Jana D'Amato Tothova, Alchimia srl (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3669. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mario Romano, Laura Giurgola, Claudio Gatto, Jana D'Amato Tothova; Evaluation of retinal viability after simulation of vitreoretinal surgery in porcine eyes ex vivo. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3669.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate retinal viability in porcine eyes ex-vivo after simulation of vitreoretinal surgery by combined use of medical devices including BSS, vitreal staining, ILM staining, perfluoroctane and silicone oil endotamponade with minimal and with residues removal.

Methods : 25 porcine eyes were obtained from local slaughterhouse, disinfected with povidone iodide 5% and vitreoretinal surgery was simulated according to the following conditions: A) No surgery control: eye bulbs were kept for 30 min at room temperature (RT); B) Sham Surgery: vitreoretinal surgery with the sole use of BSS, 30 min at RT; C) Cytotoxic control: vitreoretinal surgery with BSS, injection of 1-H-perfluorooctane on retina, contact time 30 min at RT; D) Surgery with residues: vitreoretinal surgery with the use of BSS, vitreal staining, ILM staining, perfluoroctane and silicone oil endotamponade, leaving high residues of all materials; E) Surgery with removal of residues: vitreoretinal surgery with the use of BSS, vitreal staining, ILM staining, perfluoroctane and silicone oil endotamponade with careful removal of the residues. Each simulated condition was tested at least in quadruplicate by two technicians. Immediately after surgery, the retina was extracted from each eye bulb and at least 16 samples with 3 mm diameter were prepared. Retinal cells viability was determined after extraction, using TOX-1 In Vitro Toxicology Assay Kit, MTT based (Sigma-Aldrich, Italy). A viability < 70% is the cytotoxicity threshold.

Results : Retina extracted from eye globes subjected to no surgery (A) and sham surgery (B) showed optimal cell viability (96 to 100%). Retina extracted after the surgery with residues removal (E) showed good cell viability (average 86%), while retina from eye bulbs after surgery with high residues (D) and cytotoxic control (C) resulted in high retinal cytotoxicity corresponding to low average cell viability of 40% and 29%, respectively.

Conclusions : The tested conditions indicated that vitreoretinal surgery performed with the combined use of the medical devices (vitreal stain, ILM stain, perfluoroctane and silicone oil endotamponade) do not affect retinal viability if the residues of used medical devices are properly removed. The presence and accumulation of high residues derived from the medical devices used during vitreoretinal surgery could negatively impact retinal viability.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×